Mounzer KC - Search Results

1

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA-B*5701 Screening as a Risk-Mitigation Measure.

Stainsby CM, Perger TM, Vannappagari V, Mounzer KC, Hsu RK, Henegar CE, Oyee J, Urbaityte R, Lane CE, Carter LM, Pakes GE, Shaefer MS. Stainsby CM, et al. Among authors: mounzer kc. Pharmacotherapy. 2019 Jan;39(1):40-54. doi: 10.1002/phar.2196. Epub 2018 Dec 11. Pharmacotherapy. 2019. PMID: 30414209 Free PMC article.

2

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients.

Amorosa VK, Slim J, Mounzer K, Bruno C, Hoffman-Terry M, Dorey-Stein Z, Ferrara T, Kostman JR, Lo Re V 3rd. Amorosa VK, et al. Antivir Ther. 2010;15(1):91-9. doi: 10.3851/IMP1492. Antivir Ther. 2010. PMID: 20167995 Free PMC article.

3

Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database.

Hsu R, Fusco J, Henegar C, Mounzer K, Wohlfeiler M, Vannappagari V, Aboud M, Curtis L, Fusco G. Hsu R, et al. Ther Adv Drug Saf. 2018 Oct 29;9(12):675-686. doi: 10.1177/2042098618798350. eCollection 2018 Dec. Ther Adv Drug Saf. 2018. PMID: 30546862 Free PMC article.

4

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA^® observational database: a cohort study.

Mounzer K, Hsu R, Fusco JS, Brunet L, Henegar CE, Vannappagari V, Stainsby CM, Shaefer MS, Ragone L, Fusco GP. Mounzer K, et al. AIDS Res Ther. 2019 Jan 16;16(1):1. doi: 10.1186/s12981-019-0217-3. AIDS Res Ther. 2019. PMID: 30651100 Free PMC article.

5

Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.

Mills AM, Schulman KL, Fusco JS, Brunet L, Hsu R, Beyer A, Prajapati G, Mounzer K, Fusco GP. Mills AM, et al. HIV Med. 2020 May;21(5):299-308. doi: 10.1111/hiv.12826. Epub 2020 Jan 27. HIV Med. 2020. PMID: 31985887 Free PMC article.

6

Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.

Hsu R, Brunet L, Fusco JS, Mounzer K, Vannappagari V, Henegar CE, Van Wyk J, Curtis L, Lo J, Fusco GP. Hsu R, et al. AIDS. 2021 Jan 1;35(1):81-90. doi: 10.1097/QAD.0000000000002718. AIDS. 2021. PMID: 33048874

7

Assessing bias introduced in estimated glomerular filtration rate by the inhibition of creatinine tubular secretion from common antiretrovirals.

Brunet L, Wyatt C, Hsu R, Mounzer K, Fusco J, Fusco G. Brunet L, et al. Antivir Ther. 2020;25(5):287-292. doi: 10.3851/IMP3373. Antivir Ther. 2020. PMID: 33211670

8

Antiretroviral therapy and liver disorders in the OPERA^® cohort.

Wohlfeiler M, Mounzer K, Brunet L, Fusco J, Vannappagari V, Curtis L, Payvandi N, Aboud M, Hsu R, Lackey P, Fusco G. Wohlfeiler M, et al. Ther Adv Drug Saf. 2020 Dec 8;11:2042098620976953. doi: 10.1177/2042098620976953. eCollection 2020. Ther Adv Drug Saf. 2020. PMID: 33343858 Free PMC article.

9

To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment.

Mounzer K, Brunet L, Wyatt CM, Fusco JS, Vannappagari V, Tenorio AR, Shaefer MS, Ragone L, Hsu RK, Fusco GP. Mounzer K, et al. AIDS. 2021 Jul 1;35(8):1201-1208. doi: 10.1097/QAD.0000000000002871. AIDS. 2021. PMID: 33710017

10

Weight gain before and after switch from TDF to TAF in a U.S. cohort study.

Mallon PW, Brunet L, Hsu RK, Fusco JS, Mounzer KC, Prajapati G, Beyer AP, Wohlfeiler MB, Fusco GP. Mallon PW, et al. Among authors: mounzer kc. J Int AIDS Soc. 2021 Apr;24(4):e25702. doi: 10.1002/jia2.25702. J Int AIDS Soc. 2021. PMID: 33838004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters